Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells drugs and GAP cultivation of medicinal materials in China. It offers orthopedic, cardio-cerebrovascular, digestive, supplement category, respiratory, C…
Drug Manufacturers - Specialty & Generic
CN, Xi'an [HQ]
Ratios
11 Records · Starting from 2013Margins, Growth Rates In %
| Ratio | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||
| Gross Margin | 69.18 | 70.57 | 64.66 | 63.00 | 69.23 | 71.15 | 69.50 | 62.29 | 58.28 | 58.12 | 57.92 | |
| Profit Margin | 14.52 | 16.31 | 16.65 | 12.94 | 11.60 | 13.22 | 11.75 | 11.80 | 10.50 | 10.38 | 11.26 | |
| Operating Margin | 15.13 | 17.68 | 18.86 | 14.49 | 13.30 | 13.52 | 14.14 | 14.17 | 12.68 | 12.63 | 13.75 | |
|
EPS Growth
|
- - | 21.57 | 6.45 | -7.58 | 6.56 | 15.39 | 10.67 | 10.84 | 18.48 | 8.26 | -2.54 | |
| EPS CNY | 51.00 | 62.00 | 66.00 | 61.00 | 65.00 | 75.00 | 83.00 | 92.00 | 109.00 | 118.00 | 115.00 | |
| Return on Assets (ROA) | 9.61 | 9.99 | 9.84 | 7.84 | 5.81 | 7.91 | 7.73 | 6.81 | 7.00 | 5.24 | 5.20 | |
| Return on Equity (ROE) | 15.55 | 16.32 | 14.79 | 12.06 | 7.87 | 10.58 | 10.64 | 10.98 | 11.77 | 10.88 | 7.13 | |
| Return on Invested Capital (ROIC) | 12.75 | 13.00 | 13.50 | 10.90 | 7.84 | 9.36 | 11.03 | 10.39 | 10.87 | 8.05 | 7.05 | |
| Solvency | ||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 5.84 | 9.97 | 4.62 | 3.96 | 0.40 | -0.56 | -0.24 | 5.45 | 8.02 | 20.39 | 4.82 | |
| Debt/Equity | 9.46 | 16.29 | 6.94 | 6.10 | 0.54 | -0.74 | -0.33 | 8.79 | 13.48 | 42.35 | 6.62 | |
| Debt/EBITDA | -136.00 | -116.68 | -103.29 | -188.77 | -478.57 | -95.63 | -119.46 | -272.96 | -231.58 | -275.27 | -584.06 | |
|
Debt/Capitalization
|
8.64 | 14.00 | 6.49 | 5.75 | 0.54 | -0.75 | -0.33 | 8.08 | 11.88 | 29.75 | 6.21 | |
| Long-Term Debt/Capitalization | - - | - - | - - | - - | - - | - - | - - | 6.89 | 5.00 | 2.89 | 0.14 | |
| Interest Debt per Share CNY | 0.33 | 0.67 | 0.33 | 0.33 | 0.05 | -0.05 | -0.02 | 0.77 | 1.29 | 4.76 | 1.13 | |
| Debt Growth | - - | 100.00 | -50.00 | - - | -85.00 | -100.00 | - - | - - | 68.43 | 269.01 | -73.97 | |
| Liquidity | ||||||||||||
| Current Ratio | 179.05 | 177.03 | 188.43 | 195.76 | 302.83 | 319.92 | 294.41 | 250.86 | 218.59 | 164.17 | 349.25 | |
| Quick Ratio | 153.31 | 156.16 | 165.72 | 177.54 | 284.95 | 298.58 | 269.74 | 231.57 | 203.33 | 153.69 | 333.09 | |
| Cash Ratio | 54.94 | 73.45 | 61.16 | 79.88 | 168.62 | 45.51 | 50.15 | 110.99 | 95.83 | 91.22 | 229.39 | |
| Operating Cash Flow Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Turnover | ||||||||||||
| Inventory Turnover | 219.96 | 242.15 | 302.77 | 394.11 | 362.70 | 353.89 | 321.74 | 380.71 | 554.59 | 431.17 | 531.71 | |
| Receivables Turnover | 169.31 | 203.85 | 184.37 | 200.23 | 178.73 | 201.35 | 220.39 | 161.75 | 189.42 | 174.83 | 197.48 | |
| Payables Turnover | 203.29 | 203.52 | 190.45 | 226.69 | 227.62 | 344.70 | 508.55 | 429.80 | 560.95 | 335.35 | 451.43 | |
|
Asset Turnover
|
66.19 | 61.23 | 59.10 | 60.54 | 50.04 | 59.85 | 65.74 | 57.66 | 66.72 | 50.46 | 46.16 | |
| Fixed Turnover | 490.20 | 262.40 | 219.32 | 240.43 | 268.52 | 345.27 | 423.46 | 339.56 | 322.67 | 275.42 | 263.88 | |
| Coverage | ||||||||||||
| Interest Coverage | 2,926.13 | 1,448.51 | 3,476.02 | 3,290.53 | 13,966.38 | - - | 77,272.16 | 3,333.16 | 3,220.05 | 884.08 | 2,206.78 | |
| Asset Coverage | 1,100 | 600 | 1,200 | 1,500 | 17,100 | - - | - - | 1,200 | 800 | 300 | 1,600 | |
| Cash Flow Coverage (CFGR) | 127.17 | 121.39 | 203.10 | 309.96 | 948.30 | -1,030.94 | -3,026.18 | 145.61 | 108.76 | 31.84 | 101.52 | |
| EBITDA Coverage | 2,900 | 1,800 | 4,200 | 4,100 | 17,300 | - - | 88,100 | 4,000 | 3,800 | 1,100 | 2,800 | |
| Dividend Coverage | -1,800 | -2,500 | -3,000 | -2,900 | -12,100 | -700 | -800 | -600 | -700 | -600 | -500 | |
| Time Interest Earned (TIE) | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
| Market Prospects | ||||||||||||
| Dividend Yield | 0.19 | 0.17 | 0.15 | 0.14 | 0.02 | 0.32 | 0.36 | 0.60 | 0.48 | 0.46 | 0.52 | |
| Earnings Yield | 3.53 | 4.29 | 4.57 | 4.22 | 2.32 | 2.40 | 3.01 | 3.66 | 3.48 | 3.05 | 2.99 | |
|
Price/Earnings (P/E)
|
28.3137 | 23.2903 | 21.8788 | 23.6721 | 43.1306 | 41.7002 | 33.1809 | 27.3043 | 28.7655 | 32.8029 | 33.4696 | |
| Price/Earnings Growth (PEG) | - - | 107.98 | 339.12 | -312.47 | 657.74 | 271.05 | 311.07 | 251.81 | 155.67 | 397.28 | -1,316.47 | |
|
Price/Book (P/B)
|
440.29 | 379.98 | 323.63 | 285.44 | 339.40 | 441.02 | 353.00 | 299.70 | 338.66 | 356.96 | 238.61 | |
| Price/Tangible Book (P/TB) | 440.29 | 379.98 | 323.63 | 285.44 | 339.40 | 441.02 | 353.00 | 299.70 | 338.66 | 356.96 | 238.61 | |
| Price/Sales (P/S) | 410.99 | 379.86 | 364.26 | 306.36 | 500.44 | 551.08 | 390.03 | 322.26 | 301.99 | 340.60 | 376.84 | |
|
Price/Cash Flow (P/CF)
|
3,661.91 | 1,922.13 | 2,296.54 | 1,509.41 | 6,628.07 | 5,757.67 | 3,508.34 | 2,341.97 | 2,309.71 | 2,647.10 | 3,552.33 | |
| Price/Free CF (P/FCF) | -18,199.15 | 5,785.46 | -20,929.03 | 2,082.34 | 37,704.39 | 10,070.87 | 6,936.46 | 10,258.31 | 7,579.63 | 4,772.93 | 8,898.87 | |
| Price/Operating CF (P/OCF) | 3,661.91 | 1,922.13 | 2,296.54 | 1,509.41 | 6,628.07 | 5,757.67 | 3,508.34 | 2,341.97 | 2,309.71 | 2,647.10 | 3,552.33 |